Risk-benefit value of inhaled corticosteroids: A pharmacokinetic/pharmacodynamic perspective

Chest

Volumn 123, Issue 3 SUPPL., 2003, Pages 430S-431S

  Rohatagi, Shashank ^a   Derendorf, Hartmut ^b   Zech, Karl ^c  

^a SANOFI   (France)

^b UNIVERSITY OF FLORIDA   (United States)

^c Altana Pharma Deutschland   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BUDESONIDE; CICLESONIDE; CORTICOSTEROID;

ASTHMA; CONFERENCE PAPER; DRUG BIOAVAILABILITY; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG HALF LIFE; DRUG POTENCY; DRUG SAFETY; HUMAN; LIPOPHILICITY; PLASMA PROTEIN BINDING; PRIORITY JOURNAL; RECEPTOR BINDING; RISK BENEFIT ANALYSIS; SIDE EFFECT;

EID: 0037337770     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (0)